Other studies have shown that PTGS2 is a downstream target of NF-κB and that NF-κB phosphorylation upregulates PTGS2 expression in airway epithelial cells and smooth muscle cells, thereby promoting the release of inflammatory mediators, making it a key step in the pathogenesis of asthma. This evidence concerns the gene PTGS2 and asthma.